Abstract
The incidence of osteoporosis (OP), according to the literature, is higher in females in the menopausal period, related to deficiency of the gonadal steroid, a fundamental hormone in the activity of bone remodeling, which contributes to bone growth and peak bone mass. Among the new therapies, oxytocin (OT) has been investigated for its anabolic effects on bone tissue. Objective: The objec…